Two small clinical trials tested the safety of injecting stem cells into the brains of Parkinson's patients and found no adverse effects ...

Explore Fate Therapeutics' pipeline, financials, and market position to assess if its 75% drop reflects true value or ...

Parkinson's disease (PD) is a disabling neurodegenerative disease that affects approximately 10 million people worldwide, ...

Updated clinical and preclinical data showcase iPSC-derived off-the-shelf CAR T-cell therapy products for conditioning ...

Cell therapy, specifically replenishing dopamine ... received transplantation of dopaminergic progenitors derived from human induced pluripotent stem cells into both sides of the brain.

Clinical trials show stem cell therapies for Parkinson's disease are safe, potentially offering more effective treatment with fewer side effects.

In 2020, researchers reported the first clinical application of induced pluripotent stem cells ... embryonic stem-cell line. In individuals who received a high dose of the therapy, scores used ...

Ernexa Therapeutics (Nasdaq: ERNA), developing innovative cell therapies for the treatment of advanced cancer and autoimmune ...

He pioneered the induced pluripotent stem cell (iPSc ... Japan can soon reap the benefits of its investments in stem cell therapy R&D is due to the ongoing advancement of research.

Cell-based therapies that replenish dopamine neurons in the brain are showing early promise as a potentially more effective treatment ... from human induced pluripotent stem (iPS) cells, with ...